Identification of single-dose, dual-echo based cbv threshold for fractional tumor burden mapping in recurrent glioblastoma

HIGHLIGHTS

• who: Aliya Anil et al. from the Affiliated Hospital of Guizhou Medical University, China have published the paper: Identification of single-dose, dual-echo based CBV threshold for fractional tumor burden mapping in recurrent glioblastoma, in the Journal: (JOURNAL)
• what: The authors determine optimum rCBV thresholds for the single-dose, dual-echo DSC-MRI approach to generate FTB maps that distinguish tumor and PTRE and best match with the reference standard, double-dose, single-echo FTB map. This study shows that the single-dose, dualecho protocol can be reliably used to distinguish tumor and PTRE . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.